• SC 79 and the Limits of Akt–Ferroptosis Inference

  2026-10-14

  The available ovarian-cancer study supports a relationship between obacunone exposure, reduced Akt phosphorylation, p53-associated signaling, and ferroptosis-related readouts, but it does not establish that SC 79 directly caused or reversed the observed phenotype. This editorial separates named-material evidence from vendor claims, evaluates the strength of the study’s comparators and measurements, and identifies unresolved questions about Akt pathway causality, ferroptosis specificity, model generalizability, and translational relevance.

• Berberine, Tuft Cells, and Estrogen Deficiency Bone Loss

  2026-10-14

  A preclinical study links berberine-associated changes in intestinal butyrate and tuft cells with improved gut barrier and immune balance during estrogen deficiency. The findings support a gut–bone axis mechanism, but they do not establish clinical efficacy or safety in postmenopausal patients.

• CCL5, GRA15, and Toxoplasma Brain Dissemination

  2026-10-13

  A 2026 mBio study links the Toxoplasma gondii effector GRA15 to CCL5/CCR5-dependent sequestration of infected dendritic cells in brain microvessels. The findings support a host–parasite mechanism for early CNS colonization in tested cellular and mouse models, while leaving important questions about human disease, parasite diversity, timing, and therapeutic relevance unresolved.

• Verapamil, Txnip and Osteoporosis

  2026-10-13

  A 2025 study links TXNIP variation with bone-density measures and reports that verapamil reduced bone loss in cellular and ovariectomized-mouse models. The findings support a preclinical mechanism involving ChREBP, TXNIP and bone-remodeling pathways, but do not establish clinical efficacy for osteoporosis.

• Shufeng Xingbi Therapy in an Allergic Rhinitis Rat Model

  2026-10-12

  A preprint examined whether Shufeng Xingbi Therapy was associated with improved allergic-rhinitis features, immune markers, short-chain fatty acids and gut-microbiome profiles in an ovalbumin-induced rat model. The reported results are biologically suggestive but remain preliminary because the study is small, animal-based, not peer reviewed and does not establish that microbiome changes caused the observed effects.

• Caspase-3 Signals in Hyperthermia–Cisplatin Research

  2026-10-12

  A cell-based study reported that combining hyperthermia with cisplatin enhanced caspase-8-associated apoptosis and pyroptosis, while highlighting important limits on interpreting DEVD-dependent caspase activity as a caspase-3-specific finding.

• ABT-199 and BCL-2 Inhibition: Five Evidence Questions

  2026-10-10

  This overview explains how ABT-199 and venetoclax should be interpreted alongside a preclinical colorectal cancer study, emphasizing target biology, evidence quality, compound differences, applicability, and key limitations.

• Acetylspiramycin: An Evidence-Mapping Guide

  2026-10-09

  Acetylspiramycin, also known as Spiramycin B, is more than a macrolide antibiotic profile: it is a useful case study in linking ribosomal pharmacology, susceptibility data, biosynthetic provenance, and immune-response research. This guide explains how to interpret the evidence without confusing catalog claims, assay observations, and clinically transferable conclusions.

• β-Pseudouridine in RNA Research: Evidence and Limits

  2026-10-09

  β-Pseudouridine is a naturally occurring RNA modification with important structural and translational roles. This overview separates established RNA biology from emerging vaccine-platform findings and explains why recent influenza results cannot yet be attributed specifically to β-pseudouridine.

• Single-Cell RNA Isoforms in Alzheimer’s Brain

  2026-10-08

  Shahnaee and colleagues combine single-nucleus profiling with PacBio Kinnex long-read sequencing to examine full-length RNA isoforms in post-mortem Alzheimer’s disease brain tissue. The study reveals extensive cell-type-specific isoform diversity, disease-associated transcript changes, and candidate signatures of RNA switching, while also showing why these observations require careful validation before they are interpreted as causal mechanisms.

• MEDUSA Reveals How Drug-Induced Death Changes

  2026-10-08

  Honeywell and colleagues introduce MEDUSA, a time-resolved modeling framework that separates cell growth from cell death in pooled functional genomic screens. Applied to DNA damage responses, the study finds that p53 loss can shift lethality from apoptosis toward a respiration-dependent nonapoptotic mechanism, refining how genetic drug-sensitivity data should be interpreted.

• Synthetic DEFB1 mRNA and Cryptosporidiosis

  2026-10-07

  A recent Journal of Infectious Diseases study reports that synthetic DEFB1 mRNA increased β-defensin 1 protein in human intestinal cells and reduced Cryptosporidium parvum burden in vitro. The work illustrates how host-directed mRNA therapy can be evaluated through a combination of reporter-based delivery measurements, antimicrobial-peptide quantification, infection assays, and cell-health analyses.

• ARCA EGFP mRNA: Evidence and Limits

  2026-10-07

  ARCA EGFP mRNA is a direct-detection reporter for fluorescence-based assessment of delivery and mammalian cell gene expression. The product dossier supports defined transcript specifications and a supplier-reported HEK293T benchmark, but it does not independently establish performance across cell types, instruments, or delivery systems.

• HotStart Universal 2X Green qPCR Mix Overview

  2026-10-06

  A concise, source-limited overview of APExBIO’s HotStart™ Universal 2X Green qPCR Master Mix, SKU K1170. No matched paper evidence or independent performance validation was available for this product.

• Pseudo-UTP and Pseudouridine in mRNA Research

  2026-10-06

  Pseudo-modified uridine triphosphate is relevant to mRNA research because pseudouridine-containing transcripts have been associated with improved protein expression in some experimental systems. The supplied mouse study supports a role for modified nucleotides in an mRNA vaccine context, while also showing why findings should not be generalized automatically to human vaccines, gene therapy, or every RNA design.

8707 records 1/581 page Next 12345 下5页 Last page